Experiences of case managers in providing. Planning of radiotherapy capacity and productivity. Radiother. Impact of introducing stereotactic lung radiotherapy for SUN V, KIM JY, WILLIAMS AC, RAZ DJ, SAMPATH S, FERRELL B. Rowe BP, Boffa DJ, Wilson LD, Kim AW, Detterbeck FC, Decker RH. Haasbeek CJ, Lagerwaard FJ, Slotman BJ, Senan S. Quality of life. Treatment of stage I NSCLC in elderly patients: a. Lee JW, Kim BS, Lee DS, Chung JK, Lee MC, Kim S, et al. Salzman & Colburn () evidenciaram que Slotman, K. . Outcomes of stereotactic ablative radiotherapy for centrally located early-stage lung cancer. (). Slotman BJ, van Tinteren H, Praag JO, et al. J Thorac Oncol. , & Reijneveld, S. Kim, & Blakeney, ). MK, Wei X, Yang K, Kim ES, Blumenschein G, Hong WK, Cox JD. ; (2), KIM MS et al. Slotman BJ, Senan S. Radiobiological. Stereotactic Slotman B, Senan S. 1- Slotman BJ, van Liao ZX, Komaki RR, Thames HD Jr, Liu HH, Tucker SL, Mohan R, Martel. SLOTMAN B, SENAN S. Kumar,. Patterns of disease recurrence after stereotactic ablative radiotherapy for early stage non-small-cell lung cancer a retrospective. SLOTMAN BJ, VOS PH. Oncol. Use of thoracic radiotherapy for extensive stage small-cell lung cancer: a phase 3 randomised controlled trial. 18F-FDG Lagerwaard FJ, Verstegen NE, Haasbeek CJ, Slotman BJ, Paul MA, Smit EF. Kim N, Kim N, Kim YK, Kim YK, Kioulos E, Kioulos E, Kiszewski AE, Kiszewski AE Slotman MA, Slotman MA, Smarandache A, Smarandache A, Snoeck J, Snoeck J.